European heart journal. Cardiovascular Imaging · 2025
Cardiac diagnoses and long-term outcomes in ring-like late gadolinium enhancement evaluated by cardiac magnetic resonance.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Filomena Domenico, Vandenberk Bert, Dresselaers Tom, Willems Rik, Masci Pier Giorgio, Robyns Tomas, Bogaert Jan
Аннотация
AIMS: Non-ischaemic ring-like late gadolinium enhancement (LGE) in the left ventricle (LV) detected by cardiac magnetic resonance (CMR) is an emerging biomarker associated with adverse outcomes. Data regarding ring-like LGE are limited to small patient cohorts. We aimed to assess the prevalence of ring-like LGE, its association with morpho-functional phenotypes, aetiologic background, and prognostic implications.
METHODS AND RESULTS: This single-centre observational retrospective study included consecutive patients undergoing LGE-CMR between 2002 and 2024. Ring-like LGE was defined as continuous enhancement in ≥3 adjacent segments. Ischaemic and amyloid cardiomyopathies (CMPs) were excluded. Clinical records were reviewed for etiologic diagnosis and clinical outcomes. The primary endpoint was a composite of all-cause mortality, heart transplantation, or LV assist device implantation. The secondary endpoint included sustained ventricular tachycardia, appropriate implantable cardioverter-defibrillator therapies, or sudden cardiac death. Among 14 091 unique patients who underwent LGE-CMR, ring-like LGE was identified in 152 patients (1.1%) with a median number of 10 segments, mostly involving the inferolateral segments. The most frequent morpho-functional phenotypes were dilated and non-dilated LV CMP. Genetic testing identified likely pathogenic/pathogenic variants in 59 (58.4%) patients, affecting both desmosomal and non-desmosomal genes. Inflammatory CMP was diagnosed in 15.8%. Other rare aetiologies included genetic neuromuscular diseases and inborn errors of metabolism. Primary and secondary endpoints occurred in 17.8 and 17.1%, respectively, over a median follow-up of 3 years.
CONCLUSION: Ring-like LGE is an uncommon, non-disease-specific feature found in various morpho-functional CMP phenotypes. It is associated with frequent genetically determined aetiologies and a high burden of adverse outcomes.
METHODS AND RESULTS: This single-centre observational retrospective study included consecutive patients undergoing LGE-CMR between 2002 and 2024. Ring-like LGE was defined as continuous enhancement in ≥3 adjacent segments. Ischaemic and amyloid cardiomyopathies (CMPs) were excluded. Clinical records were reviewed for etiologic diagnosis and clinical outcomes. The primary endpoint was a composite of all-cause mortality, heart transplantation, or LV assist device implantation. The secondary endpoint included sustained ventricular tachycardia, appropriate implantable cardioverter-defibrillator therapies, or sudden cardiac death. Among 14 091 unique patients who underwent LGE-CMR, ring-like LGE was identified in 152 patients (1.1%) with a median number of 10 segments, mostly involving the inferolateral segments. The most frequent morpho-functional phenotypes were dilated and non-dilated LV CMP. Genetic testing identified likely pathogenic/pathogenic variants in 59 (58.4%) patients, affecting both desmosomal and non-desmosomal genes. Inflammatory CMP was diagnosed in 15.8%. Other rare aetiologies included genetic neuromuscular diseases and inborn errors of metabolism. Primary and secondary endpoints occurred in 17.8 and 17.1%, respectively, over a median follow-up of 3 years.
CONCLUSION: Ring-like LGE is an uncommon, non-disease-specific feature found in various morpho-functional CMP phenotypes. It is associated with frequent genetically determined aetiologies and a high burden of adverse outcomes.